What move does the options market price into Baxter International's report?

Implied ±14.8%, either direction · provisional.

How often does Baxter International move more than the options market prices?

6 of the last 8 reports moved at least as far as the implied move.

BAXNYSESurgical & Medical Instruments & Apparatus

Baxter International Inc (BAX) earnings date, market-implied expected move, and options open interest by expiry

26.41

+0.92 · +3.60%

post 26.41 0.00%

Closed16:00 ET

Open25.72Volume10.5MMkt cap$13.7BEPS-1.43Div yield0.15%

Day25.72 – 27.0253%52-wk15.72 – 29.9975%

BAX

Baxter International Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±14.8%implied · straddle

22.5730.43

spot 26.50exp Feb 19ATM strike 27.5ATM straddle 4.63IV 40%

Nov 4 closeprovisional

Expected move

Inputs

Next report

Feb 11

before open · in 99 days

est.Q4 FY26

Calendar

Next report

Last report

−7.70%

vs ±7.6% implied · ×1.01

shaded = implied · ▲▼ = realized

Oct 29 '26 · confirmed

Implied vs realized

Linked news

1dRARE · customerUltragenyx posts net loss of $118 million, revenue $173 million for Q3
34dCAH · supplierCardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health

News

Largest filed tie

13F top-10 QoQ

+5.17%

shares held · 10 largest managers

13F · Jun 30 '26128d lag

688 managers

Top fund weight

0.25%

BAX weight · RSP

N-PORTJul 31 '26

9 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Baxter International (BAX) is expected to report on Feb 11 before open (estimated date).

Implied vs realized

8 reports

6 of 8≥ implied

avg implied: ±7.4%
avg realized: ±10.3%

Feb 20 '25Feb 20 '25confirmed±6.1%▲+8.50%×1.39

May 1 '25May 1 '25confirmed±6.4%▼−1.60%×0.25

Jul 31 '25Jul 31 '25confirmed±5.4%▼−22.42%×4.19

Oct 30 '25Oct 30 '25confirmed±8.6%▼−14.54%×1.70

Feb 12 '26Feb 12 '26confirmed±8.4%▼−15.99%×1.91

Q1 FY26Apr 30 '26confirmed±8.9%▲+4.02%×0.45

Q2 FY26Jul 30 '26confirmed±7.7%▲+7.99%×1.04

Q3 FY26Oct 29 '26confirmed±7.6%▼−7.70%×1.01

quarterimplied−25%0+25%realized×

Q3 FY26±7.6%▼−7.70%×1.01

Q2 FY26±7.7%▲+7.99%×1.04

Q1 FY26±8.9%▲+4.02%×0.45

Feb '26±8.4%▼−15.99%×1.91

Oct '25±8.6%▼−14.54%×1.70

Jul '25±5.4%▼−22.42%×4.19

2 older reports

May '25±6.4%▼−1.60%×0.25

Feb '25±6.1%▲+8.50%×1.39

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 10 expiries · Nov 3 close

0.73OI · 10 expiries · Nov 3 closeP/C open interest · Feb 19 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

6 nearer expiries

333+48%Nov 62d0.093,621+6%0.09

377+2%Nov 139d1.26300+26%1.26

3,064−18%Nov 2016d0.2711,192+2%0.27

121+6%Nov 2723d0.35342+18%0.35

1—Dec 430d0.001,639+81850%0.00

1000%Dec 1137d1.8255+1275%1.82

4,1290%Dec 1844d0.834,995+35%0.83

9,5280%Jan 1572d0.4222,8360%0.42

report · Feb 11 · before open · est.

850+32%Feb 19107d1,161+64%

1,722+1%Mar 19135d0.622,7620%0.62

ExpiryPutsCallsP/C

6 nearer expiries

Nov 62d333+48%3,621+6%0.09

Nov 139d377+2%300+26%1.26

Nov 2016d3,064−18%11,192+2%0.27

Nov 2723d121+6%342+18%0.35

Dec 430d1—1,639+81850%0.00

Dec 1137d1000%55+1275%1.82

Dec 1844d4,1290%4,995+35%0.83

Jan 1572d9,5280%22,8360%0.42

report · Feb 11 · before open · est.

Feb 19107d850+32%1,161+64%0.73

Mar 19135d1,722+1%2,7620%0.62

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±14.8%

Funds 4

RSP±0.0%

XLV±0.0%

REVS±0.0%

FB±0.0%

Dashed = straddleMethod 2 more funds Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ3 FY26

9.88%as filednet margin · revenue +0.54% QoQ · +4.97% YoY

Revenue

$3.0B+0.54% QoQ

Gross profit

$994M−3.68% QoQ

33.40% margin

Operating income

$225M+3.69% QoQ

7.56% margin

Pre-tax income

$417M+163.92% QoQ

Net income

$294M+133.33% QoQ

9.88% margin

Cost of revenue

$2.0B+2.80% QoQ

Operating expenses

$769M−5.64% QoQ

SG&A $730M

R&D $125M

Tax

$119M+417.39% QoQ

Other income

$192M+425.42% QoQ

Revenue$3.0B+0.54%

Gross profit

$994M−3.68%

33.40% margin

Operating income

$225M+3.69%

7.56% margin

Pre-tax income

$417M+163.92%

Net income

$294M+133.33%

9.88% margin

Cost of revenue

$2.0B+2.80%

Operating expenses

$769M−5.64%

SG&A $730M

R&D $125M

Other income$192M+425.42%

Tax$119M+417.39%

flow · deduction · inflow · signed % = QoQSource: SEC filings · standardized · QE Sep 30 '26 · width = $

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 4 close · Hatch = extended hours · ▯ up · ▮ down · bars = volume, 15mSource: market data · 16:00 ET

Intraday

Event sensitivity

PCE ×1.80· ±2.8% vs ±1.6% · 19 releases

eventrelease day|move|up · n×base

PCEpersonal income & outlays±2.8%12 of 19×1.80

Baxter International Inc (BAX) earnings date, market-implied expected move, and options open interest by expiry

Implied vs realized

Implied vs realized

Positioning

Positioning

Linked exposure

Linked exposure

Revenue flow

Revenue flow

Intraday

Intraday

Event sensitivity

Implied vs realized

Positioning

Revenue flow

Event sensitivity

Earnings history

Methodology

Baxter International Inc (BAX) earnings date, market-implied expected move, and options open interest by expiry

Intraday

Linked exposure

Quarter	Reported	EPS	Consensus
Q3 FY26	Oct 29 '26 · confirmed	0.57	—
Q2 FY26	Jul 30 '26 · confirmed	0.24	—
Q1 FY26	Apr 30 '26 · confirmed	-0.03	—